Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
The Journal of General Virology
|
January 21, 2003
Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost
Lasse Vinner, Edmund G-T Wee, Sandip Patel, et al.
Vaccine
|
July 27, 2005
Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants
Jennifer A Slyker, Barbara L Lohman, Dorothy A Mbori-Ngacha, et al.
The Lancet. Oncology
|
November 3, 2009
Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009
Joseph T Wee, Benjamin O Anderson, June Corry, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 11, 2021
Intratumoral CD39<sup>+</sup>CD8<sup>+</sup> T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLC
Joe Yeong, Lisda Suteja, Yannick Simoni, et al.
The Journal of General Virology
|
March 25, 2004
A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans
Matilu Mwau, Inese Cebere, Julian Sutton, et al.
The Lancet. Microbe
|
November 29, 2024
Safety and immunogenicity of the ChAdOx1-MVA-vectored conserved mosaic HIVconsvX candidate T-cell vaccines in HIV-CORE 005.2, an open-label, dose-escalation, first-in-human, phase 1 trial in adults living without HIV-1 in the UK
Nicola Borthwick, Natalia Fernandez, Peter J Hayes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 21, 2017
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
Anne W Lee, Wai Tong Ng, Jian Ji Pan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 6, 2019
International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma
Anne W Lee, Wai Tong Ng, Jian Ji Pan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 11, 2021
International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma
Wai Tong Ng, Yoke Lim Soong, Yong Chan Ahn, et al.
The Lancet. Oncology
|
December 1, 2022
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic
Victor Ho-Fun Lee, Marlinda Adham, Wala Ben Kridis, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
The Journal of General Virology
|
January 21, 2003
Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost
Lasse Vinner, Edmund G-T Wee, Sandip Patel, et al.
Vaccine
|
July 27, 2005
Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants
Jennifer A Slyker, Barbara L Lohman, Dorothy A Mbori-Ngacha, et al.
The Lancet. Oncology
|
November 3, 2009
Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009
Joseph T Wee, Benjamin O Anderson, June Corry, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 11, 2021
Intratumoral CD39<sup>+</sup>CD8<sup>+</sup> T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLC
Joe Yeong, Lisda Suteja, Yannick Simoni, et al.
The Journal of General Virology
|
March 25, 2004
A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans
Matilu Mwau, Inese Cebere, Julian Sutton, et al.
The Lancet. Microbe
|
November 29, 2024
Safety and immunogenicity of the ChAdOx1-MVA-vectored conserved mosaic HIVconsvX candidate T-cell vaccines in HIV-CORE 005.2, an open-label, dose-escalation, first-in-human, phase 1 trial in adults living without HIV-1 in the UK
Nicola Borthwick, Natalia Fernandez, Peter J Hayes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 21, 2017
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
Anne W Lee, Wai Tong Ng, Jian Ji Pan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 6, 2019
International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma
Anne W Lee, Wai Tong Ng, Jian Ji Pan, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 11, 2021
International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma
Wai Tong Ng, Yoke Lim Soong, Yong Chan Ahn, et al.
The Lancet. Oncology
|
December 1, 2022
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic
Victor Ho-Fun Lee, Marlinda Adham, Wala Ben Kridis, et al.
Page
of 6